Hematoloxía
Servicio
University of Paris-Sorbonne
París, FranciaPublicacións en colaboración con investigadores/as de University of Paris-Sorbonne (5)
2024
-
Activity and safety of eltrombopag in combination with cyclosporin A as first‑line treatment of adults with severe aplastic anaemia (SOAR): a phase 2, single-arm study
The Lancet Haematology, Vol. 11, Núm. 3, pp. e206-e215
2022
-
Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT
Bone Marrow Transplantation, Vol. 57, Núm. 3, pp. 416-422
-
Correction: Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT (Bone Marrow Transplantation, (2022), 57, 3, (416-422), 10.1038/s41409-021-01553-x)
Bone Marrow Transplantation
-
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
New England Journal of Medicine, Vol. 386, Núm. 1, pp. 11-23
2015
-
Azacitidine frontline therapy for unfit acute myeloid leukemia patients: Clinical use and outcome prediction
Leukemia Research, Vol. 39, Núm. 3, pp. 296-306